DNA vaccines for the prevention and treatment of allergy
Authors:
- Kaw Yan ChuaKCKaw Yan Chua
- I-Chun KuoIKI-Chun Kuo
- Chiung-Hui HuangCHChiung-Hui Huang
- 1 February 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 9 (1) , 50-54
Abstract
Antiallergy DNA vaccine is an attractive alternative for the prevention and treatment of allergic diseases. This review covers recent studies to enhance potency and safety of antiallergy DNA vaccines. Dendritic cell-targeted allergen gene vaccination using fascin gene promoter inhibited IgE production and allergic inflammation but not airway hyperresponsiveness. Targeting allergen expression at immature dendritic cells or induction of tolerogenic dendritic cells could induce antiallergic T regulatory cells. Vaccination with DNA-encoded Ag85B and AIMP1 as adjuvants could downregulate established Th2-mediated allergic responses. Forced ubiquitation or targeting allergens to lysosomal/endosomal compartments could avoid risk of allergen sensitization. Gene gun delivery of conventional antiallergy DNA vaccine is a risk factor. Replicase-based allergy DNA vaccines showed enhanced immunogenecity and safety as compared to conventional DNA vaccines. TANK-binding kinase-1 (TBK1) is a novel key molecule in DNA vaccine-induced immunogenicity. Dendritic cell-based approach has been actively explored to enhance immunogenicity of antiallergy DNA vaccines. Codelivery of hypoallergenic DNA vaccines with potent adjuvants via a desirable delivery mode will help to fulfill the requirements for clinical application of antiallergy DNA vaccines. Activation of TBK1 signaling pathway could be a novel strategy to enhance immunogenicity of DNA vaccines.Keywords
This publication has 32 references indexed in Scilit:
- Current progress of DNA vaccine studies in humansExpert Review of Vaccines, 2008
- Divergent Effects of Biolistic Gene Transfer in a Mouse Model of Allergic Airway InflammationAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Improving vaccines by incorporating immunological coadjuvantsExpert Review of Vaccines, 2007
- Human dendritic cells transfected with allergen‐DNA stimulate specific immunoglobulin G4 but not specific immunoglobulin E production of autologous B cells from atopic individuals in vitroImmunology, 2007
- Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cellsExpert Review of Vaccines, 2007
- Is Genetic Vaccination against Allergy Possible?International Archives of Allergy and Immunology, 2006
- Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cellsJournal of Allergy and Clinical Immunology, 2006
- Modification of the human allergic immune response by allergen-DNA–transfected dendritic cells in vitroJournal of Allergy and Clinical Immunology, 2004
- Transcriptional targeting of dendritic cells in gene gun-mediated DNA immunization favors the induction of type 1 immune responsesMolecular Therapy, 2003
- Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascinGene Therapy, 2003